Table 1 Percent of scenarios with disagreement in first-round (pre-meeting) and second-round (post-meeting) ratings
From: Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy
| Â | N | Round 1 disagreement | Round 2 disagreement |
|---|---|---|---|
Overall | 735 | 40% | 6% |
Part I: Should a test of corneal sensitivity be performed? | 646 | 42% | 7% |
 Scenarios that differed by degree of epithelial defect | |||
  No epithelial changes (no staining) or defect | 256 | 38% | 1% |
  Newly observed epithelial changes (staining) but no defect | 256 | 45% | 14% |
  Newly observed defect | 128 | 46% | 3% |
 Scenarios that differed by history of diabetes | |||
  No diabetes or with well-controlled diabetes without evidence of end-organ damage | 320 | 32% | 3% |
  Persistent poorly controlled diabetes and/or with evidence of end-organ damage | 320 | 53% | 10% |
Part II: Rate the adequacy tests to diagnose and stage neurotrophic keratopathy | 20 | 25% | 10% |
Part III: Rate the appropriateness various treatments | 69 | 20% | 3% |
 Scenarios that differed by disease stage | |||
  Stage 1 | 23 | 26% | 4% |
  Stage 2 | 23 | 17% | 0% |
  Stage 3 | 23 | 17% | 4% |
 Scenarios that differed by treatment type | |||
  Medical management | 27 | 22% | 0% |
  Non-surgical intervention | 24 | 25% | 4% |
  Surgical intervention | 15 | 13% | 7% |